Characterization of the extracellular domain in vascular endothelial growth factor receptor-1 (Flt-1 tyrosine kinase).
about
Vascular endothelial growth factor-B in physiology and diseaseVascular endothelial growth factor receptor-1 (VEGFR-1/Flt-1): a dual regulator for angiogenesisFlt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in micesFlt Multivalent Conjugates Inhibit Angiogenesis and Improve Half-Life In VivoComputational modeling of interacting VEGF and soluble VEGF receptor concentration gradients.Serum-dependence of affinity-mediated VEGF release from biomimetic microspheresTherapeutic potential of manipulating VEGF splice isoforms in oncologyVascular endothelial growth factor receptor-2 in breast cancer.Involvement of Flt-1 (VEGF receptor-1) in cancer and preeclampsia.Full-length human placental sFlt-1-e15a isoform induces distinct maternal phenotypes of preeclampsia in mice.VEGFR and type-V RTK activation and signalingVEGF-VEGFR Signals in Health and Disease.Targeted therapies in the management of colorectal carcinoma: role of bevacizumab.Targeted therapy with bevacizumab (Avastin) for metastatic colorectal cancer.Comparison of the effects of marchantin C and fucoidan on sFlt-1 and angiogenesis in glioma microenvironment.Characterization of vascular endothelial cell growth factor interactions with the kinase insert domain-containing receptor tyrosine kinase. A real time kinetic study.A set of loop-1 and -3 structures in the novel vascular endothelial growth factor (VEGF) family member, VEGF-ENZ-7, is essential for the activation of VEGFR-2 signaling.VEGF and Notch in tip and stalk cell selectionInduction of tube formation by angiopoietin-1 in endothelial cell/fibroblast co-culture is dependent on endogenous VEGF.Suppression of ovarian cancer by muscle-mediated expression of soluble VEGFR-1/Flt-1 using adeno-associated virus serotype 1-derived vector.Structure and function of vascular endothelial growth factor and its receptor system.Skeletal muscle VEGF gradients in peripheral arterial disease: simulations of rest and exercise.Mapping of the Sites Involved in Ligand Association and Dissociation at the Extracellular Domain of the Kinase Insert Domain-containing Receptor for Vascular Endothelial Growth Factor
P2860
Q27003400-01BBCA45-21A3-453E-87AE-3F97A5C7AE6DQ28274365-E8BCD19B-F86F-4CB9-ACA0-B81620DC143EQ28504776-9D47AF96-4CDF-4A69-B0DC-3B0482413CD5Q28552652-E558D7A9-06D1-4ACD-9402-EFD6288C828DQ30430268-49B6B591-2FB6-43C8-92B6-C10082235604Q33761778-0508D081-45E1-4096-A79F-C327DCCE3BCDQ33888458-78A4F7ED-6F65-489A-B7AB-66E55684E3C0Q33912620-47D35387-BAE6-4F0F-A940-BDD363A0FA8CQ35145097-C7AE5BE6-3F83-4091-A332-698534D77C25Q35362708-AD2FC7A6-F733-40F7-9550-B20AC8C34120Q37197494-296BAC5A-EFDD-4282-B3F9-6BE32A689FECQ37606226-8C77D2FF-8C9C-4341-86B0-4920413C59D1Q37771243-C637D9E0-C0A2-42BB-9D7E-3C3E03501B49Q37942733-927CB5E4-9A38-4A35-A43F-E6F53B55631BQ39379250-E77384A3-A357-4405-ADB1-7BE64C0238FCQ40947530-BA0A4DAF-1CEB-435F-B65E-A7929847246EQ42049137-B7A79F59-FFA3-42E3-A33A-6CE14EC02430Q42099822-89B776B5-E86B-4655-BB9C-5AD694FC7678Q42447371-EFCDBD30-AABA-40B1-A09F-96BD434B58D1Q45410669-B067526D-09CB-429E-83F6-923FE7C1E6F2Q49346926-CDD04091-0B48-4E51-9830-9BA8FA554C9CQ50905577-2B12C068-223E-4BAC-BE43-218A59AFBF88Q57980717-81D6F8C5-6BEA-4EC3-B536-CC8A45747472
P2860
Characterization of the extracellular domain in vascular endothelial growth factor receptor-1 (Flt-1 tyrosine kinase).
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Characterization of the extrac ...... tor-1 (Flt-1 tyrosine kinase).
@en
type
label
Characterization of the extrac ...... tor-1 (Flt-1 tyrosine kinase).
@en
prefLabel
Characterization of the extrac ...... tor-1 (Flt-1 tyrosine kinase).
@en
P2093
P2860
P1476
Characterization of the extrac ...... tor-1 (Flt-1 tyrosine kinase).
@en
P2093
P2860
P304
P356
10.1111/J.1349-7006.1997.TB00463.X
P577
1997-09-01T00:00:00Z